Viewing Study NCT01585233


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-06-16 @ 3:59 PM
Study NCT ID: NCT01585233
Status: COMPLETED
Last Update Posted: 2025-11-17
First Post: 2012-04-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Moderate Psoriasis View
None Severe Psoriasis View
None Skin disease View
None ASKP1240 View
None CD40 antigen View
None Anti-CD40 monoclonal antibody View